Dalia Megiddo

Dalia Megiddo is the founder of Nasus Pharma Ltd. (2019), holding the title of Director, Chief Development & Medical Officer.
Dr. Megiddo was the founder of Alcobra Ltd. (2008), holding the title of Director from 2008 to 2013.
Dr. Megiddo was the founder of Bioblast Pharma Ltd. (2012), holding the title of Director, Chief Executive & Medical Officer from 2018 to 2019.
Dr. Megiddo was the founder of Medingo Ltd. (2005), holding the title of Director from 2005 to 2007.
Former jobs include Director at Elron Ventures Ltd., Director at Given Imaging Ltd., Director at AngioScore LLC, Director at VYNE Pharmaceuticals Ltd. from 2016 to 2019, Director at Impliant Ltd., Director at Barnev, Inc., Director at Glucon Medical Ltd., Managing Director at 7-Health Ventures Ltd. from 2007 to 2009, Director at Notal Vision Ltd., Director at Epitomee Medical Ltd., Director at Chiasma (Israel) Ltd., Director at Bioblast Ltd., and Director at Chiasma, Inc. from 2002 to 2008.
Education includes an MBA from Recanati School of Business Administration and a doctorate from The Hebrew University Hadassah Medical School.